Immuneering (IMRX) Total Liabilities (2020 - 2024)
Historic Total Liabilities for Immuneering (IMRX) over the last 5 years, with Q3 2024 value amounting to $10.8 million.
- Immuneering's Total Liabilities rose 986.47% to $10.8 million in Q3 2024 from the same period last year, while for Sep 2024 it was $10.8 million, marking a year-over-year increase of 986.47%. This contributed to the annual value of $12.0 million for FY2023, which is 406.38% down from last year.
- As of Q3 2024, Immuneering's Total Liabilities stood at $10.8 million, which was up 986.47% from $10.8 million recorded in Q2 2024.
- In the past 5 years, Immuneering's Total Liabilities ranged from a high of $12.5 million in Q4 2022 and a low of $2.8 million during Q4 2020
- In the last 5 years, Immuneering's Total Liabilities had a median value of $9.9 million in 2023 and averaged $9.2 million.
- As far as peak fluctuations go, Immuneering's Total Liabilities surged by 28294.13% in 2021, and later crashed by 1640.15% in 2023.
- Quarter analysis of 5 years shows Immuneering's Total Liabilities stood at $2.8 million in 2020, then surged by 282.94% to $10.7 million in 2021, then grew by 16.71% to $12.5 million in 2022, then dropped by 4.06% to $12.0 million in 2023, then decreased by 9.76% to $10.8 million in 2024.
- Its last three reported values are $10.8 million in Q3 2024, $10.8 million for Q2 2024, and $9.3 million during Q1 2024.